Xtrackers MSCI World Health Care

Global companies

(XWHS)
£41.21
Previous business day’s close price
+£2.50 (+6.45%)
max available period
£37.33
£45.20

17 Aug 23
12 Dec 24

Details

ETF description

This ETF aims to invest in companies that operate within the global healthcare sector. It includes a variety of businesses involved in pharmaceuticals, biotechnology, medical devices, and healthcare services. By tracking a specific index that represents this sector, the ETF provides investors with a way to gain exposure to companies that are working to improve health outcomes and innovate in medical treatments.

Investors interested in the healthcare industry may find this ETF appealing, especially those looking for growth opportunities as the sector continues to evolve. The healthcare field often experiences demand regardless of economic conditions, making it a sector that some investors view as resilient

Issuer details

Xtrackers is a large and established provider of high quality ETFs and exchange traded commodities (ETCs). It is the ETF and ETC segment of the German asset manager DWS.

Xtrackers ETFs are listed on eleven stock exchanges globally and have over £169.53bn (as at June 2024) in assets under management, making Xtrackers one of the largest providers of ETFs and ETCs by AUM.

Index details

The MSCI World Health Care TRN Index aims to reflect the performance of large and mid‑cap companies from global developed markets part of the Health care sector as classified by GICS. Weighted by free‑float adjusted market capitalisation and is reviewed on a quarterly basis.

ETF Breakdown

Lilly
8.5%
Unitedhealth Group Inc
7.2%
Johnson & Johnson
4.8%
Novo Nordisk As Class B
4.5%
Abbvie Inc
3.9%
Merck & Co Inc
3.2%
Thermo Fisher
2.7%
Novartis AG
2.7%
Abbott Laboratories
2.6%
Astrazeneca plc
2.6%
Intuitive Surgical Inc
2.5%
AMGEN Inc.
2.1%
Danaher Corp.
2.1%
Pfizer Inc.
2.0%
Stryker Corp.
1.7%
Boston Scientific Corp.
1.7%
Vertex Pharmaceuticals, Inc.
1.7%
Bristol‑Myers Squibb Co.
1.5%
Gilead Sciences, Inc.
1.5%
Sanofi
1.5%
Medtronic Plc
1.5%
Elevance Health Inc
1.2%
Cigna Group (The)
1.2%
CSL Ltd.
1.2%
Regeneron Pharmaceuticals, Inc.
1.1%
Mckesson Corporation
1.0%
Zoetis Inc
1.0%
GSK Plc
0.9%
EssilorLuxottica
0.9%
HCA Healthcare Inc
0.9%
CVS Health Corp
0.9%
Becton, Dickinson And Co.
0.9%
Daiichi Sankyo Co., Ltd.
0.7%
Hoya
0.6%
Lonza Group AG
0.6%
Amerisource Bergen Corp.
0.6%
Alcon
0.6%
Takeda Pharmaceutical Co
0.6%
Edwards Lifesciences Corp
0.5%
Agilent Technologies Inc.
0.5%
IQVIA
0.5%
Ge Healthcare Technologies Inc
0.5%
argenx SE
0.5%
Veeva Systems Inc
0.5%
Idexx Laboratories, Inc.
0.5%
Humana Inc.
0.5%
Resmed Inc.
0.4%
Alnylam Pharmaceuticals Inc
0.4%
Centene Corp.
0.4%
Chugai Ro Co Ltd
0.4%
Cardinal Health, Inc.
0.4%
Dexcom Inc
0.4%
Mettler‑Toledo International, Inc.
0.3%
Terumo Corporation
0.3%
West Pharmaceutical Services, Inc.
0.3%
Otsuka Holdings Co Ltd
0.3%
UCB SA
0.3%
Biogen Inc
0.3%
Illumina Inc
0.3%
Waters Corp.
0.3%
Zimmer Biomet Holdings Inc
0.3%
Steris Plc
0.3%
Bayer AG
0.3%
Koninklijke Philips N.V.
0.3%
Labcorp Holdings Inc Usd Npv
0.3%
Merck KGAA
0.3%
Cooper Inc
0.3%
Astellas Pharma Inc.
0.3%
Olympus Corp.
0.2%
Teva‑ Pharmaceutical Industries Ltd.
0.2%
Insulet Corporation
0.2%
Sandoz Group Ag Chf 0.05
0.2%
Hologic, Inc.
0.2%
Sonova Holding AG
0.2%
Molina Healthcare Inc
0.2%
Quest Diagnostics, Inc.
0.2%
United Therapeutics Corp
0.2%
Baxter International Inc.
0.2%
Coloplast AS
0.2%
Viatris Inc
0.2%
Align Technology, Inc.
0.2%
Siemens Healthineers AG
0.2%
Perkinelmer, Inc.
0.2%
Fresenius SE & Co. KGaA
0.2%
Avantor
0.2%
Straumann Holding AG
0.2%
Genmab
0.2%
Moderna Inc
0.2%
Incyte Corp.
0.2%
Fisher & Paykel Healthcare Corporation Limited
0.2%
Biomarin Pharmaceutical Inc.
0.2%
Cochlear Ltd.
0.2%
Neurocrine Biosciences, Inc.
0.2%
Universal Health Services, Inc.
0.2%
Bio‑Techne Corp
0.2%
Catalent Inc.
0.1%
Charles River Laboratories International Inc.
0.1%
Smith & Nephew plc
0.1%
Shionogi & Co. Ltd.
0.1%
Roche Holding AG
0.1%
Solventum Corp
0.1%
Sysmex Corporation
0.1%
Royalty Pharma plc
0.1%
Qiagen N.V.
0.1%
Exact Sciences Corp.
0.1%
Teleflex Incorporated
0.1%
Fresenius Medical Care AG & Co. KGaA
0.1%
Henry Schein Inc.
0.1%
DaVita Inc
0.1%
Eisai Co Ltd
0.1%
Sonic Healthcare
0.1%
Pro Medicus
< 0.1%
Zealand Pharma A/S.
< 0.1%
Bio‑Rad Laboratories Inc.
< 0.1%
Eurofins Scientific S.E.
< 0.1%
Sartorius AG
< 0.1%
Deutsche Global Liquidity Seri
< 0.1%
Swedish Orphan Biovitrum AB
< 0.1%
Recordati Industria Chimica e Farmaceutica SpA
< 0.1%
Galderma Group Ag
< 0.1%
Sartorius Stedim Biotech S.A.
< 0.1%
Orion Corp (finland)
< 0.1%
Ramsay Health Care
< 0.1%
Biomerieux
< 0.1%
Ono Pharmaceutical Co. Ltd
< 0.1%
Ipsen
< 0.1%
Kyowa Kirin Co. Ltd.
< 0.1%
Getinge AB
< 0.1%
M3, Inc.
< 0.1%
Hikma Pharmaceuticals Plc
< 0.1%
Demant AS
< 0.1%
Grifols SA
< 0.1%
Amplifon
< 0.1%
Bachem Holding AG
< 0.1%
Diasorin S.p.A.
< 0.1%
Carl Zeiss Meditec
< 0.1%
Others
< 0.1%
£41.21
Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 700+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
Browse investments

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.

ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.
Whenever you invest, your capital is at risk
This could mean the value of your investments goes down as well as up.
Understand more about investment risk.
© InvestEngine Limited 2024. All rights reserved.